Mar 1, 2011
By:
Andrea LaFountain
With an emphasis on short-term objectives rather than long-term goals, pharma is missing a huge opportunity in applying market science to drive adherence
|
Dec 1, 2010
By:
Andrea LaFountain
Putting science front-and-center in the design of patient adherence programs can lead to a better understanding of the commitment required to get patients to take their medicine
|
Sep 1, 2010
By:
Andrea LaFountain
When neither attitudes nor personality drive behavior, Pharma must look to social norms to understand consumer adherence issues
|
|